Listen to the Quality Discussion

FDA Guidance: “Contract Manufacturing Arrangements for Drugs: Quality Agreements”

The FDA comment period for the new guidance ended July 29. This is your opportunity to listen to the questions and comments prior to submission. During this webinar you will hear directly from the FDA on what is addressed in the new draft guidance.

What you can expect:

  • During this webinar, you will hear directly from the FDA important details covered in the new draft guidance on quality agreements, as well as expectations.
  • You will also hear from industry experts and gain insights from other webinar participants.
  • You will also hear from industry experts and gain insights from other webinar participants.

Featured Speakers